Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications (Q35651511)

9 August 2017

1 reference

title

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications (English)

1 reference

9 August 2017

M Y Donath

1

1 reference

PubMed ID

14767595

9 August 2017

P A Halban

series ordinal

2

1 reference

9 August 2017

7 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

47

1 reference

9 August 2017

581-589

1 reference

9 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1336-4

9 August 2017

0 references

cites work

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

The in vivo regulation of pulsatile insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

The life story of the pancreatic B cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Islet growth and development in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Studies in the diabetic mutant mouse: III. Physiological factors associated with alterations in beta cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

beta-cell neogenesis during prolonged hyperglycemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic β-Cell Mass in Vivo in Adult Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Endoplasmic reticulum stress and the development of diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Overstimulation and beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Lipoapoptosis: its mechanism and its diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Monolayer Culture of Adult Rat Pancreatic Islets on Extracellular Matrix: Modulation of B-Cell Function by Chronic Exposure to High Glucose*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Improvement in insulin secretion in diabetes after diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Changing Prevalence of Overweight Children and Adolescents at Onset of Insulin-Treated Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Increased islet apoptosis in Pdx1+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

The Diabetes Prevention Program (DPP): description of lifestyle intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Obesity, increased linear growth, and risk of type 1 diabetes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

Inhibition of glucose-induced insulin secretion by long-term preexposure of pancreatic islets to leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1336-4

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

12 December 2020

Endoplasmic reticulum stress and diabetes mellitus.

1 reference

12 December 2020

Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).

1 reference

12 December 2020

The adipoinsular axis: effects of leptin on pancreatic beta-cells

1 reference

12 December 2020

Is type 2 diabetes a chronic inflammatory/autoimmune disease?

1 reference

12 December 2020

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic

1 reference

12 December 2020

Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity

1 reference

12 December 2020

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity

1 reference

12 December 2020

Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes

1 reference

12 December 2020

Beta-cell ontogeny: growth and death

1 reference

12 December 2020

Processing of engulfed apoptotic bodies yields T cell epitopes

1 reference

12 December 2020

Insulin-secreting beta-cell dysfunction induced by human lipoproteins

1 reference

12 December 2020

Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes

1 reference

12 December 2020

Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes

1 reference

12 December 2020

Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited.

1 reference

12 December 2020

Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse

1 reference

12 December 2020

Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response?

1 reference

12 December 2020

Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes.

1 reference

12 December 2020

Quantitative estimation of the pancreatic islet tissue in diabetic subjects

1 reference

12 December 2020

Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay

1 reference

12 December 2020

10.1007/S00125-004-1336-4

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14767595